Published: Mar 9, 2026
Written by Klarity Editorial Team
Published: Mar 9, 2026

If you’re dealing with fatigue, low libido, or other symptoms of low testosterone, you might be wondering: Can I actually get treatment through telehealth? The short answer is yes—and in 2025, it’s more accessible than ever.
Online low testosterone treatment has become a legitimate, regulated option for men across the United States. Thanks to advances in telemedicine and recent regulatory changes, you can now consult with licensed healthcare providers, get proper lab work, and receive prescriptions for medications like Clomid (clomiphene) or testosterone therapy—all from home.
But navigating the rules can be confusing. Federal telehealth flexibilities are set to expire soon, state laws vary widely, and not all online clinics follow best practices. This guide will walk you through everything you need to know about getting low T treatment online in 2025, including what’s legal, what’s safe, and how to find quality care.
Low testosterone (hypogonadism) affects millions of American men, particularly those over 40. Symptoms include decreased energy, reduced muscle mass, mood changes, and diminished sexual function. Yet many men avoid seeking treatment due to inconvenience, stigma, or difficulty accessing specialists.
Telehealth removes many of these barriers. Instead of multiple office visits to an endocrinologist or urologist, you can consult with qualified providers via video call, coordinate lab work at a local facility, and have prescriptions sent directly to your pharmacy.
Whether you’re seen in-person or online, legitimate low testosterone diagnosis requires:
The American Urological Association’s guidelines emphasize that diagnosis should never be made on symptoms alone—lab confirmation is essential. Quality telehealth providers follow these same evidence-based protocols.
During the COVID-19 pandemic, the Drug Enforcement Administration (DEA) temporarily suspended the Ryan Haight Act’s in-person examination requirement for prescribing controlled substances via telemedicine. This meant doctors could prescribe medications like testosterone (a Schedule III controlled substance) through telehealth without meeting patients face-to-face first.
This flexibility has been extended three times—most recently in November 2024—and is currently set to expire December 31, 2025. As of late 2025, you can still receive controlled substance prescriptions (including testosterone injections, gels, or pellets) through telehealth appointments without an initial in-person visit.
The DEA has proposed new telemedicine regulations that would require either:
However, these rules have faced significant pushback from healthcare providers, patient advocates, and telehealth companies. Many experts expect another extension into 2026, but nothing is guaranteed. If you’re considering telehealth low T treatment, it’s wise to start sooner rather than later.
Here’s important news: Clomiphene citrate (Clomid), a common alternative to testosterone therapy, is not a controlled substance. This means it has never been subject to the Ryan Haight Act’s restrictions.
Doctors can legally prescribe Clomid via telehealth anywhere in the United States (subject only to state laws, discussed below). This makes Clomid-based treatment an attractive option for men who want to boost their testosterone naturally while preserving fertility.
While federal law sets the baseline, individual states can impose additional requirements for telehealth prescribing. Let’s look at the rules in major states:
California: Allows telehealth prescribing if the provider establishes a ‘good faith prior examination’ of the patient—which can be done entirely via video. California recently moved to permit even asynchronous (questionnaire-based) evaluations for certain conditions. NPs have full independent practice authority and can prescribe both Clomid and testosterone.
New Hampshire: In August 2025, New Hampshire eliminated its in-person exam requirement for controlled substance prescriptions via telehealth. Providers can now prescribe Schedule II-IV medications remotely, provided patients receive an in-person evaluation at least once every 12 months (which can be with any licensed prescriber, not necessarily the telehealth doctor).
Delaware: Has no state-level in-person visit requirement for telehealth prescribing. Recent legislation (SB 101, July 2025) further clarified that medications for opioid use disorder can be prescribed via telemedicine, aligning state law with federal guidelines.
Alabama: Requires an in-person visit within 12 months if a patient receives telehealth treatment more than four times for the same condition. This can be satisfied by seeing a local collaborating provider.
Georgia: Mandates that patients be examined in-person by a Georgia-licensed provider before initiating telehealth treatment, with efforts to arrange annual in-person exams thereafter. (Note: Georgia NPs cannot prescribe testosterone since it’s Schedule III, but they can prescribe Clomid under physician supervision.)
Texas: NPs can prescribe most medications but are prohibited from prescribing Schedule II controlled substances in outpatient settings. They must work under a collaborative agreement with a physician. Telehealth prescribing is explicitly legal, with no in-person mandate for non-controlled medications.
Florida: Removed its ban on telehealth prescribing of Schedule III-V controlled substances in 2023, but Schedule II medications (like Adderall) still cannot be prescribed via telehealth except in specific settings (psychiatric care, hospice, inpatient facilities). NPs require physician supervision to prescribe controlled substances.
Clomiphene is FDA-approved for female fertility issues but is widely used off-label for male hypogonadism. It works by blocking estrogen receptors in the brain, which signals the pituitary gland to produce more luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This, in turn, stimulates the testes to produce more testosterone naturally.
Advantages of Clomid:
Considerations:
Testosterone is available as injections, gels, patches, or subcutaneous pellets. It’s classified as a Schedule III controlled substance due to potential for abuse and diversion.
Advantages of TRT:
Considerations:
Look for services that:
Red flags to avoid:
At Klarity Health, we connect patients with board-certified healthcare providers who are licensed in your state, require proper diagnostic workup including lab confirmation, and follow evidence-based treatment protocols. Our providers have flexible availability (often same-day or next-day appointments), transparent pricing, and accept both insurance and cash payment.
You’ll provide information about:
If you haven’t had recent labs, your provider will order:
You can get these drawn at any major lab (Quest, LabCorp, etc.) near you. Many telehealth providers coordinate directly with lab facilities to make this seamless.
During your video visit (typically 20-30 minutes), your provider will:
This consultation establishes the provider-patient relationship required by law in most states. It’s not just a rubber stamp—expect a thorough evaluation.
If treatment is warranted, your provider will electronically prescribe your medication to a pharmacy of your choice. Most states now mandate e-prescribing for all medications, making the process quick and secure.
For controlled substances like testosterone, your provider will check your state’s prescription monitoring program (PMP) database to ensure you’re not receiving duplicate prescriptions from multiple sources—a standard safety measure.
Responsible low T treatment requires ongoing monitoring:
Your telehealth provider should schedule regular check-ins, either via video or phone. Some states require periodic in-person evaluations (see state-specific rules above), which can often be satisfied by seeing your primary care physician.
Medical doctors and doctors of osteopathy have full prescribing authority in all states. They can prescribe both Clomid and testosterone via telehealth, subject to federal and state regulations.
NP prescribing authority varies significantly by state:
Full Practice Authority States: In states like California, New York, and New Hampshire, NPs can independently evaluate and prescribe low T medications (including testosterone) without physician supervision.
Collaborative Practice States: In states like Texas and Florida, NPs must work under a collaborative agreement with a physician. They can typically prescribe Clomid independently but may need physician oversight for controlled substances like testosterone.
Restricted States: Georgia and Oklahoma prohibit NPs from prescribing Schedule II or Schedule III controlled substances (which includes testosterone). However, NPs can still prescribe Clomid for low T in these states.
PAs work under physician supervision in all states, but the degree of oversight varies. Most states allow PAs to prescribe controlled substances (including testosterone) under a supervising physician’s protocol. The supervising MD doesn’t need to see every patient, but they must maintain a collaborative relationship with the PA.
No reputable provider will prescribe testosterone or Clomid based solely on symptoms. The American Urological Association is clear: diagnosis requires both biochemical evidence (low lab values) and clinical symptoms.
Beware of services that:
Your provider should explain:
One-and-done prescribing is not appropriate for hormone therapy. Expect:
Legitimate telehealth services will:
In November 2024, a federal jury convicted the founder of a telehealth ADHD startup for running what prosecutors called a ‘fraud scheme’ that resulted in over 40 million Adderall pills being prescribed without proper medical evaluations. This marked the first federal prosecution of a telehealth company for controlled substance distribution.
The case sent shockwaves through the telehealth industry and underscored the importance of proper medical oversight. Federal authorities are now scrutinizing telehealth prescribing more closely, particularly for controlled substances.
What this means for patients:
This crackdown is actually good news for patients seeking legitimate care—it’s weeding out bad actors and protecting the telehealth industry for those who use it responsibly.
Many telehealth low T services operate on a cash-pay basis, with typical costs:
Some telehealth platforms accept insurance for:
At Klarity Health, we work with most major insurance plans and also offer transparent cash-pay pricing for those without coverage or who prefer not to use insurance. Our model ensures you know the cost upfront—no surprise bills.
Often, yes—especially when you factor in:
However, if you have excellent insurance coverage with low copays, traditional in-person care might be comparable in cost.
The DEA’s COVID-era flexibilities are set to expire December 31, 2025. Here’s what could happen:
Given strong opposition to new restrictions, Congress or the DEA may extend current flexibilities into 2026. This would maintain the status quo.
The DEA might finalize its proposed regulations requiring:
If this happens, existing patients would likely be grandfathered in, but new patients would need an in-person visit before starting testosterone therapy online.
Individual states might pass laws explicitly permitting telemedicine prescribing of controlled substances (as New Hampshire recently did), creating a patchwork of regulations.
If you’re considering low T treatment via telehealth:
Reputable telehealth companies are monitoring these developments closely and will help patients navigate any transitions.
At Klarity Health, we believe quality men’s health care should be convenient, transparent, and personalized. Our approach to telehealth low testosterone treatment includes:
✅ Licensed providers in your state – Every consultation is with a board-certified physician, nurse practitioner, or physician assistant licensed where you live
✅ Evidence-based protocols – We follow clinical guidelines, requiring proper lab work and documentation before prescribing
✅ Flexible appointment availability – Often same-day or next-day video consultations that fit your schedule
✅ Transparent pricing – You’ll know the cost upfront, whether you’re using insurance or paying cash
✅ Comprehensive care coordination – We can order labs, send prescriptions to your local pharmacy, and communicate with your other providers
✅ Ongoing support – Regular follow-ups to monitor your progress and adjust treatment as needed
Our providers take time to understand your symptoms, explain your options (including whether Clomid or testosterone is right for you), and create a treatment plan tailored to your needs and goals.
Yes, as of late 2025, it’s federally legal to receive testosterone prescriptions via telehealth without an in-person visit, thanks to extended COVID-era flexibilities. However, some states have additional requirements (like periodic in-person exams), and federal rules may change after December 31, 2025.
Absolutely. Clomid (clomiphene) is not a controlled substance, so it can be prescribed via telehealth in all 50 states (subject only to standard medical practice requirements). It’s an excellent option for men who want to boost testosterone while preserving fertility.
Yes. Any legitimate provider will require lab confirmation of low testosterone (typically two morning readings below 300 ng/dL) before prescribing treatment. Beware of services that don’t require labs—they’re not following proper medical protocols.
It depends on your state. In states with full NP practice authority (like California, New York, New Hampshire), NPs can independently prescribe both Clomid and testosterone. In collaborative practice states (like Texas and Florida), NPs can prescribe under physician supervision. A few states (like Georgia) restrict NP prescribing of controlled substances like testosterone.
Expect an initial follow-up at 3 months to assess your response to treatment, then typically every 6-12 months thereafter. You’ll also need periodic lab work to monitor testosterone levels and ensure safety. Some states require annual in-person evaluations.
Some states (like Georgia and Alabama) do require periodic in-person exams. Your telehealth provider can often coordinate with a local physician or clinic to satisfy this requirement—you don’t necessarily need to travel to see your telehealth doctor in person.
Many insurance plans cover telehealth consultations and lab work, and most cover the medications themselves if they’re on your formulary. Coverage varies by plan, so check with your insurance provider. Many patients find that even cash-pay telehealth is affordable compared to traditional in-person specialty care.
Look for providers who:
Avoid services that offer prescriptions with minimal evaluation or that seem too good to be true.
Telehealth has fundamentally changed how men can access low testosterone care. What once required multiple specialist visits, time off work, and potential stigma can now be handled discreetly and conveniently from home—without sacrificing quality or safety.
As we navigate the evolving regulatory landscape of 2025 and beyond, one thing is clear: telehealth for low T is here to stay. Whether federal rules tighten or continue their current flexibility, demand for accessible, affordable men’s health care will continue to drive innovation in this space.
The key is choosing a provider that prioritizes medical excellence over convenience shortcuts—one that requires proper diagnosis, provides ongoing monitoring, and treats you as a partner in your care rather than just a prescription request.
If you’re experiencing symptoms of low testosterone, don’t let barriers of time, distance, or uncertainty keep you from getting evaluated. Quality telehealth services can connect you with experienced providers who can help you feel like yourself again.
Ready to take the next step? Klarity Health offers convenient telehealth consultations with licensed providers who specialize in men’s health. Get started with a same-day or next-day appointment, transparent pricing, and a treatment plan tailored to your needs.
This article is for informational purposes only and does not constitute medical advice. Always consult with a licensed healthcare provider about your specific medical situation. Telehealth regulations are subject to change; verify current rules in your state.
Verified as of: December 17, 2025
DEA Rules Status: COVID-19 telehealth flexibilities for controlled substances extended through December 31, 2025 (third extension in November 2024). No new DEA final rule in effect yet (special registration pending). Non-controlled substance prescribing via telehealth remains unrestricted federally (Ryan Haight Act in-person rule applies only to controlled drugs).
States Verified: Texas (November 2025), California (July 2025), Florida (2022–2023 law changes), New York (May 2025), Georgia (November 2025), Alabama (November 2025), New Hampshire (August 2025)
Sources Newer Than 2024: 12 of 15 sources (80%) are from 2025; remaining are late-2024 or authoritative 2023 updates.
⚠️ Flagged for Follow-Up: DEA’s proposed telemedicine regulations (special registration) – no final action as of December 2025. Monitor DEA for a likely 4th extension into 2026. Check state laws in 2026 for any newly effective telehealth or NP practice changes.
DEA and HHS Announcement (November 15, 2024) – ‘DEA and HHS Extend Telemedicine Flexibilities Through 2025’ – Official DEA press release confirming third extension of COVID-era telehealth prescribing flexibilities for controlled substances through December 31, 2025. www.dea.gov
JD Supra (McDermott Will & Emery, November 19, 2025) – ‘DEA Signals Extension of Telemedicine Flexibilities into 2026’ – Expert legal analysis confirming current federal telehealth status, DEA proposed rulemaking delays, and implications for controlled substance prescribing via telemedicine. www.jdsupra.com
Sheppard Mullin Law Blog (August 15, 2025) – ‘Telehealth and ‘In-Person’ Visits: A 50-State Survey’ – Comprehensive state-by-state analysis of telehealth prescribing requirements, in-person exam mandates, and 2025 regulatory updates including California AB 1503, New York DOH rules, and New Hampshire SB 252. www.jdsupra.com
American Urological Association (AUA, Reviewed 2024) – ‘Testosterone Deficiency Guideline’ – Clinical practice guidelines establishing diagnostic criteria for low testosterone (two testosterone measurements <300 ng/dL plus symptoms) and evidence-based treatment recommendations. www.auanet.org
New Hampshire Legislature (Effective August 2025) – ‘SB 252: Relative to Telehealth Services’ – State legislation eliminating prior in-person examination requirement for controlled substance prescribing via telemedicine, requiring only annual in-person evaluation by any licensed prescriber. legiscan.com
Find the right provider for your needs — select your state to find expert care near you.